New potentiators of ineffective antibiotics: Targeting the Gram-negative outer membrane to overcome intrinsic resistance
- PMID: 34808425
- DOI: 10.1016/j.cbpa.2021.102099
New potentiators of ineffective antibiotics: Targeting the Gram-negative outer membrane to overcome intrinsic resistance
Abstract
Because of the rise in antibiotic resistance and the dwindling pipeline of effective antibiotics, it is imperative to explore avenues that breathe new life into existing drugs. This is particularly important for intrinsically resistant Gram-negative bacteria, which are exceedingly difficult to treat. The Gram-negative outer membrane (OM) prevents the entry of a plethora of antibiotics that are effective against Gram-positive bacteria, despite the presence of the targets of these drugs. Uncovering molecules that increase the permeability of the OM to sensitize Gram-negative bacteria to otherwise ineffective antibiotics is an approach that has recently garnered increased attention in the field. In this review, we survey chemical matter which has been shown to potentiate antibiotics against Gram-negative bacteria by perturbing the OM. These include peptides, nanoparticles, macromolecules, antibiotic conjugates, and small molecules.
Keywords: Adjuvant; Antibiotic; Drug discovery; Gram-negative; Lipopolysaccharide; Outer membrane; Potentiator; Resistance.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Outer Membrane Disruption Overcomes Intrinsic, Acquired, and Spontaneous Antibiotic Resistance.mBio. 2020 Sep 22;11(5):e01615-20. doi: 10.1128/mBio.01615-20. mBio. 2020. PMID: 32963002 Free PMC article.
-
Plantaricin A, Derived from Lactiplantibacillus plantarum, Reduces the Intrinsic Resistance of Gram-Negative Bacteria to Hydrophobic Antibiotics.Appl Environ Microbiol. 2022 May 24;88(10):e0037122. doi: 10.1128/aem.00371-22. Epub 2022 May 2. Appl Environ Microbiol. 2022. PMID: 35499329 Free PMC article.
-
Genetic and Chemical Screening Reveals Targets and Compounds to Potentiate Gram-Positive Antibiotics against Gram-Negative Bacteria.ACS Infect Dis. 2022 Oct 14;8(10):2187-2197. doi: 10.1021/acsinfecdis.2c00357. Epub 2022 Sep 13. ACS Infect Dis. 2022. PMID: 36098580
-
Synergy by Perturbing the Gram-Negative Outer Membrane: Opening the Door for Gram-Positive Specific Antibiotics.ACS Infect Dis. 2022 Sep 9;8(9):1731-1757. doi: 10.1021/acsinfecdis.2c00193. Epub 2022 Aug 10. ACS Infect Dis. 2022. PMID: 35946799 Free PMC article. Review.
-
Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of gram-negative bacteria.Ann Med. 2001 Apr;33(3):167-71. doi: 10.3109/07853890109002073. Ann Med. 2001. PMID: 11370769 Review.
Cited by
-
Innovative Biomedical and Technological Strategies for the Control of Bacterial Growth and Infections.Biomedicines. 2024 Jan 13;12(1):176. doi: 10.3390/biomedicines12010176. Biomedicines. 2024. PMID: 38255281 Free PMC article. Review.
-
Antibiotic Potentiation as a Promising Strategy to Combat Macrolide Resistance in Bacterial Pathogens.Antibiotics (Basel). 2023 Dec 11;12(12):1715. doi: 10.3390/antibiotics12121715. Antibiotics (Basel). 2023. PMID: 38136749 Free PMC article. Review.
-
Murepavadin induces envelope stress response and enhances the killing efficacies of β-lactam antibiotics by impairing the outer membrane integrity of Pseudomonas aeruginosa.Microbiol Spectr. 2023 Sep 5;11(5):e0125723. doi: 10.1128/spectrum.01257-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37668398 Free PMC article.
-
Profiling cell envelope-antibiotic interactions reveals vulnerabilities to β-lactams in a multidrug-resistant bacterium.Nat Commun. 2023 Aug 9;14(1):4815. doi: 10.1038/s41467-023-40494-5. Nat Commun. 2023. PMID: 37558695 Free PMC article.
-
Penetration through Outer Membrane and Efflux Potential in Pseudomonas aeruginosa of Bulgecin A as an Adjuvant to β-Lactam Antibiotics.Antibiotics (Basel). 2023 Feb 9;12(2):358. doi: 10.3390/antibiotics12020358. Antibiotics (Basel). 2023. PMID: 36830269 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
